Study Assessing PTI-428 Safety, Tolerability, Pharmacokinetics and Effect in Subjects With Cystic Fibrosis
Clinical trial NCT03591094 · COMPLETED
Trial details
- NCT number
- NCT03591094
- Sponsor
- Proteostasis Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-21
- Primary completion
- 2019-02-18
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.